Hosted on MSN37m
FDA approves BMS’ Opdivo Qvantig for solid tumour indications
The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo Qvantig for ...
Pharmaceutical Technology55m
Ipilimumab + nivolumab by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
Ipilimumab + nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase ...
Pharmaceutical Technology55m
Ipilimumab + nivolumab by Bristol-Myers Squibb for Metastatic Uveal Melanoma: Likelihood of Approval
Ipilimumab + nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase I for Metastatic Uveal Melanoma. According to GlobalData, Phase I drugs for Metastatic Uveal ...
Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?
Best Stocks for 10 Years. In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands ...